M. Puntous

Anti-cancer natural products isolated from chinese medicinal herbs

Advances in stem cell mobilization

Perspectives on cancer therapy-induced mucosal injury

Neutrophils at work

Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia

Advances in stem cell mobilization

Melphalan plus total body irradiation (MEL-TBI) or cyclophosphamide (MEL-CY) as a conditioning regimen with second autotransplant in responding patients with myeloma is inferior compared to historical controls receiving tandem transplants with melphalan alone

Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

Transplantation-associated thrombotic microangiopathy after steroid pulse therapy for polyserositis related to graft-versus-host disease

Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?

Vascular disorders of the liver # †

Review of 1027 Patients With Newly Diagnosed Multiple Myeloma

Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells

Long‐term hematologic reconstitution after autologous peripheral blood progenitor cell transplantation: a comparison between controlled‐rate freezing and uncontrolled‐rate freezing at 80°C

Defining the Intensity of Conditioning Regimens: Working Definitions

Veno-Occlusive Disease of the Liver after High-Dose Cytoreductive Therapy with Busulfan and Melphalan for Autologous Blood Stem Cell Transplantation in Multiple Myeloma Patients

A prospective study comparing vancomycin and teicoplanin as second‐line empiric therapy for infection in neutropenic patients

Multiple Myeloma in Young Patients: Clinical Presentation and Treatment Approach

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue

2002 Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer

Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma

An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: developed for the American Society of Hematology.

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy

Evaluation of Hematological Reconstitution Potential of Autologous Peripheral Blood Progenitor Cells Cryopreserved by a Simple Controlled-Rate Freezing Method

Peripheral Blood Progenitor Cell Transplantation in 118 Patients with Hematological Malignancies: Analysis of Factors Affecting the Rate of Engraftment

Treatment of Relapsed or Refractory Acute Leukemia: Comparison of Two Different Regimens

Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myeloma.

Quantitation of resistance of leukemic cells to cytosine arabinoside from BrdUrd/DNA bivariate histograms

Detection of cytarabine resistance in patients with acute myelogenous leukemia using flow cytometry

Response to recombinant interferon alpha in patients with chronic myelogenous leukemia in a single center: results and analysis of predictive factors.

Vascular endothelial lesion in patients undergoing bone marrow transplantation.

Detection of cytarabine resistance in patients with acute myelogenous leukemia using flow cytometry

Busulphan and melphalan prior to autologous transplantation for myeloid malignancies.